- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01859663
Comparison of Lifestyle Markers Between Women With and Without Polycystic Ovary Syndrome
Baseline Assessment of Dietary Intake and Physical Activity in Women With Polycystic Ovary Syndrome (PCOS)
Study Overview
Status
Detailed Description
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects 6-12% of reproductive-aged women within the general population. Currently, there is limited knowledge on the current lifestyles of women with PCOS and the psychosocial factors associated with PCOS.
The researchers plan to examine potential lifestyle differences and psychosocial factors between PCOS and healthy women. The Research Team is also interested in the relationships between biological markers and lifestyle endpoints in women with and without PCOS. Previous literature has shown there are biological marker differences between those with and without PCOS. By examining these relationships, researchers may further understand whether PCOS status is associated with lifestyle parameters.
To accomplish these objectives, 360 women (120 women with PCOS, 120 women without PCOS and with normal menstrual cycles, and 120 women without PCOS and with irregular menstrual cycles) will be included in this study. An equal number of lean and overweight/obese women will be recruited within each group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2). Women will be included in the PCOS group if they have a confirmed PCOS diagnosis from their primary care provider. Participants will complete a food frequency questionnaire, a sleep questionnaire, and a physical activity questionnaire. A researcher may also provide participants with a waist-worn accelerometer to monitor physical activity and a wrist-worn accelerometer to monitor sleep for a week. Ultrasound scans of the ovaries will be assessed and the following metabolic parameters will be assessed: (1) 75-gram oral glucose tolerance test; (2) dual X-ray absorptiometry (DXA) scan; (3) vitals and anthropometry assessment to measure waist and hip circumference, height, weight, blood pressure, and heart rate; (4) fasting blood tests to detect androgens (i.e., total testosterone, androstenedione, free androgen index); and (5) an (optional) subcutaneous fat biopsy. Women with and without PCOS will also be asked to complete a questionnaire that will assess the psychosocial factors (e.g., health beliefs). This can be conducted online, in person, or through phone.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Marla E. Lujan, PhD
- Phone Number: 607-255-3153
- Email: MEL245@cornell.edu
Study Locations
-
-
New York
-
Ithaca, New York, United States, 14853
- Human Metabolic Research Unit, Cornell University
-
Rochester, New York, United States, 14623
- Strong Fertility Center
-
Rochester, New York, United States, 14642
- CRC at University of Rochester Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Between 18 and 48 years
- BMI ≥ 18 kg/m2
- If ≥ 21 years old, must have completed a pelvic exam in the past 2 years
- In PCOS if: Confirmed PCOS diagnosis from their primary care provider
Exclusion Criteria:
- Use of oral contraceptives, fertility medications, or any drugs known to influence reproductive function
- Pregnant or breastfeeding
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
---|
Women with a past diagnosis of PCOS
We aim to recruit 120 women with a past diagnosis of PCOS.
An equal number of lean and overweight/obese women will be recruited within this group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2).
|
Women with a history of regular menstrual cycles
We aim to recruit 120 women with a history of regular menstrual cycles.
An equal number of lean and overweight/obese women will be recruited within this group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2).
|
Women with a history of irregular menstrual cycles
We aim to recruit 120 women with a history of irregular menstrual cycles, and no previous diagnosis of PCOS.
An equal number of lean and overweight/obese women will be recruited within this group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Differences in diet between women with and without PCOS
Time Frame: 1 week
|
A food frequency questionnaire will be administered to assess diet composition for the last three months.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Androgen concentrations
Time Frame: 1 day
|
Total testosterone, androstenedione and free androgen index concentrations in serum will be determined and compared across groups.
|
1 day
|
LH-FSH ratio
Time Frame: 1 day
|
The ratio of circulating LH to FSH concentrations in the serum will be determined for each participant and compared across groups
|
1 day
|
Menstrual Cycle Length
Time Frame: 1 day
|
Average menstrual cycle length as determined by self-reported history will be determined and compared across groups
|
1 day
|
Differences in exercise between women with and without PCOS
Time Frame: 1 week
|
An accelerometer will be administered to assess physical activity for 1 week.
|
1 week
|
Differences in psychosocial factors (e.g., health beliefs) of women with and without PCOS
Time Frame: 1-2 weeks
|
A questionnaire will be administered to assess psychosocial factors of women with PCOS.
|
1-2 weeks
|
Differences in sleep patterns between women with and without PCOS
Time Frame: 6 consecutive nights
|
A wrist-worn accelerometer will be administered to assess sleep patterns for 6 consecutive nights.
|
6 consecutive nights
|
Hirsutism Score
Time Frame: 1 day
|
Degree of hirsutism as judged by the Ferriman-Gallwey scale will be determined and compared across groups Degree of hirsutism as judged by the Ferriman-Gallwey scale will be determined and compared across groups |
1 day
|
Body Mass Index
Time Frame: 1 day
|
The ratio of weight to height will be determined and compared across groups.
|
1 day
|
Waist-to-Hip Ratio
Time Frame: 1 day
|
The ratio of waist circumference to hip circumference will be determined and compared across groups
|
1 day
|
Ovarian Volume
Time Frame: 1 day
|
The size of each ovary will be determined using ultrasonography for each participant during study participation and compared between groups.
|
1 day
|
Insulin Sensitivity
Time Frame: 1 day
|
Insulin sensitivity will be determined by administration of an oral glucose tolerance test and compared between groups.
|
1 day
|
Serum progesterone concentration
Time Frame: 1 day
|
The serum progesterone concentration will be determined during study participation, assessed in association with luteal dynamics and compared between groups.
|
1 day
|
Blood pressure
Time Frame: 1 day
|
Blood pressure will be determined and compared between groups.
|
1 day
|
Serum markers of metabolic syndrome
Time Frame: 1 day
|
Lipids, glucose and HbA1C concentrations will be determined and compared between groups.
|
1 day
|
Body fat distribution
Time Frame: 1 day
|
Percentage and distribution of fat and lean mass as assessed using DXA technology will be compared between groups.
|
1 day
|
Subcutaneous fat biopsy (optional)
Time Frame: 1 day
|
Subcutaneous fat cells, which represent important sites of reproductive hormone synthesis, will be assessed and compared across groups
|
1 day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marla E. Lujan, PhD, Cornell University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Neoplasms
- Endocrine System Diseases
- Disease
- Ovarian Cysts
- Cysts
- Ovarian Diseases
- Adnexal Diseases
- Gonadal Disorders
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Genital Diseases
- Genital Diseases, Female
- Polycystic Ovary Syndrome
- Syndrome
Other Study ID Numbers
- IRB 1303003665
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Ovary Syndrome
-
Cairo UniversityCompleted
-
Alexandria UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Egypt
-
Saudi German Hospital - MadinahCompletedPolycystic Ovary Syndrome (PCOS)Saudi Arabia
-
Assaf-Harofeh Medical CenterUnknownInfertility | Polycystic OvariesIsrael
-
University of CopenhagenCompletedPolycystic Ovary Syndrome (PCOS)Denmark
-
Odense University HospitalCompleted
-
Fundació Sant Joan de DéuRecruitingPolycystic Ovary Syndrome (PCOS)Norway, Austria, Denmark, Italy, Spain, Turkey
-
Riphah International UniversityCompleted
-
Dexa Medica GroupCompletedPolycystic Ovary Syndrome (PCOS)Indonesia
-
Virginia Commonwealth UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedPolycystic Ovary Syndrome (PCOS)United States